Moore & Van Allen Law Firm, Attorneys

News Room

{ Banner Image }

MVA advises Capital Vision Services during acquisition

September 2019

Moore & Van Allen’s client Capital Vision Services, LP (“CVS”), manager of the MyEyeDr. optometry practices, was acquired by the merchant-banking division of Goldman Sachs Group Inc. from Altas Partners LP and Caisse de dépôt et placement du Québec on August 29.

The primary MVA  corporate attorneys assisting in the representation of CVS on this matter were Members Hal Levinson and Bill Zimmern and Associates Courtenay Clark, Kathryn Hesman, and Ethan Clark.  The specialists advising CVS on this transaction were Real Estate Associates Holly Bannerman, Peter Reinsel and Alan Lanier; Tax Members Rob Fisher and Rachel Coyne and Counsel Randy Clark; Employee Benefits & Compensation Member Danny Johnson and Associate Janet Higley; Employment & Labor Member Karin McGinnis; Intellectual Property Member Emmett Weindruch and Associate Tucker McKinley. Altas Partners was represented by one of its regular outside firms.

The MVA team has completed over 275 practice acquisitions for CVS since our representation began in 2012.  CVS expects continued growth, and we are pleased that MVA continues to represent CVS.

About CVS

CVS supports independent optometrists and practices affiliated with the MyEyeDr. brand by providing them with financial, marketing, human-resources, claims processing and accounting services.  There are more than 550 MyEyeDr. locations offering vision-care services, prescription eyeglasses, sunglasses and contact lenses.

About Altas Partners LP

Altas is an investment firm with a long-term orientation, focused on delivering outstanding results through the active ownership of high-quality businesses. Based in Toronto, Altas Partners LP manages more than $6 billion of assets.  

About Goldman Sachs Group Inc.

Goldman’s merchant-banking division manages equity and credit investments across corporate, real estate and infrastructure strategies. Since 1986, it has invested roughly $180 billion, including in the health-care sector.